8-K
File 001-39988
8-K
- Filing date
- 11 May 2023
- Reporting date
- 11 May 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
Bolt Biotherapeutics, Inc. reports
- Company location
- Redwood City, CA
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
Bolt Biotherapeutics, Inc. has filed 290 SEC EDGAR filings since 07 May 2015
SEC filing history
Showing 26-44 of 44 matching filings.
Per page
25
Current page
2
8-K
File 001-39988
8-K
- Filing date
- 29 Mar 2023
- Reporting date
- 29 Mar 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K
- Filing date
- 14 Dec 2022
- Reporting date
- 14 Dec 2022
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K
- Filing date
- 10 Nov 2022
- Reporting date
- 10 Nov 2022
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K
- Filing date
- 10 Aug 2022
- Reporting date
- 10 Aug 2022
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K
- Filing date
- 10 Jun 2022
- Reporting date
- 10 Jun 2022
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K
- Filing date
- 12 May 2022
- Reporting date
- 12 May 2022
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K
- Filing date
- 30 Mar 2022
- Reporting date
- 30 Mar 2022
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K
- Filing date
- 04 Mar 2022
- Reporting date
- 01 Mar 2022
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K EIRGENIX AMENDMENT
- Filing date
- 25 Jan 2022
- Reporting date
- 25 Jan 2022
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K NEW DIRECTOR ONETTO
- Filing date
- 16 Dec 2021
- Reporting date
- 13 Dec 2021
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K BDC-1001 INTERIM DATA
- Filing date
- 06 Dec 2021
- Reporting date
- 06 Dec 2021
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K DIRECTOR APPOINTMENT
- Filing date
- 19 Nov 2021
- Reporting date
- 15 Nov 2021
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K Q3'21 ER
- Filing date
- 09 Nov 2021
- Reporting date
- 09 Nov 2021
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
Q2'21 EPR 8-K
- Filing date
- 12 Aug 2021
- Reporting date
- 12 Aug 2021
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
GENMAB AGREEMENT PRESS RELEASE 8-K
- Filing date
- 02 Jun 2021
- Reporting date
- 02 Jun 2021
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K
- Filing date
- 13 May 2021
- Reporting date
- 13 May 2021
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-39988
8-K
- Filing date
- 31 Mar 2021
- Reporting date
- 31 Mar 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-39988
8-K
- Filing date
- 09 Feb 2021
- Reporting date
- 09 Feb 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing